Introduction
============

Development of multidrug resistance in bacterial pathogens has created special problem for antibiotic therapy ([@B29]). Therefore, new drug target identification and development of new therapeutics to combat bacterial infection is currently needed. The attenuation of virulence factors and pathogenicity of bacteria through interfering quorum sensing (QS) is a possible alternative to killing or inhibiting growth of pathogenic bacteria ([@B17]; [@B42]; [@B18]). Many researchers have indicated that QS which regulates the expression of many virulence traits in pathogenic bacteria as an attractive anti-infective drug target ([@B48]; [@B41]). Autoinducer (AI), diffusible signaling molecules, regulate QS which allow bacteria to change their behavior in population density-dependent manner ([@B57]; [@B12]). AIs used by Gram negative bacteria are mainly *N*-Acyl homoserine lactones (AHLs) that play key roles in the virulence of pathogenic bacteria including *Pseudomonas aeruginosa* ([@B55]). *P. aeruginosa*, opportunistic pathogens, preferably infects the individuals with defective immune systems ([@B51]). The production of the majority of the virulence factors has been demonstrated to be regulated by one of the three QS systems, LasIR, RhlIR and PQS ([@B30]; [@B48]; [@B26]).

*Pseudomonas* produces Las- and Rhl-dependent virulence factors and biofilm formation to facilitate the infection ([@B51]; [@B55]; [@B6]). Bacterial biofilm development depends on release of extracellular polymeric compounds and QS mediated swimming and swarming motility ([@B40]; [@B25]). The bacteria in biofilm mode of growth become many fold tolerant to antibiotics than planktonic state of growth ([@B4]). Biofilm formation inside the host resulted in successful establishment of pathogens and development of chronic infections in human ([@B6]). The agents which obstruct bacterial QS and lead to the suppression of production of virulence factors are termed as QS inhibitors ([@B10]). Such compounds were first reported in halogenated furanones of marine algae *Delisea pulchra* by [@B20], but were found to be toxic and unstable.

Antibacterial activity of compounds from plants has been studied extensively. To obtain novel anti-QS agents, many workers have focused on natural products, because of the contribution in drug discovery. Recently, medicinal and food plants have been found to possess anti-QS property as reviewed by many workers ([@B34]; [@B22]; [@B27]; [@B62]). Therefore, inhibition of QS has been envisioned to be the new target for developing anti-infective therapies because obstruction of QS will weaken the virulence of invading pathogens, making them more susceptible to the applied mode of treatment and facilitating easy clearance by host defense mechanism. However, discovery of therapeutically effective and safe anti-QS compounds is still in the stage of infancy and needs further exploration from natural products. In an ongoing screening program we have identified some potential anti-QS plants including *Mangifera indica* L.

*Mangifera indica* L. (Mango; family Anacardiaceae) has been shown to possess various medicinal properties ([@B46]). Polyphenolics, flavonoids and triterpenoids are the chief chemical constituents present in the plant. We have previously reported that leaf extract of *M. indica* demonstrated antibacterial, antifungal and antioxidant properties and we hypothesized that it may also be a potential source of anti-QS compounds. Therefore, in this manuscript we study the broad spectrum anti-QS and anti-biofilm properties of different fractions from ML extract against tester strains including *Chromobacterium violaceum*, *P. aeruginosa* PAO1 and *Aeromonas hydrophila*.

Materials and Methods {#s1}
=====================

Bacterial Strains
-----------------

*Chromobacterium violaceum* (12472), produces QS-regulated purple-colored pigment, violacein. *C. violaceum* (CVO26) is a Tn5 mutant strain derived from wild-type *C. violaceum* (CV31532) and it is unable to produce its own AHL, but retain the ability to respond against exogenous butanoyl (C~4~) and hexanoyl (C~6~) homoserine lactones ([@B31]). *P. aeruginosa* PAO1 is a pathogenic bacterium having QS-controlled virulence factors. These cultures were kindly provided by Dr. Robert J. C. Mclean, Texas State University, San Marcos, TX, USA. *Escherichia coli* MG4/pKDT17 is *E. coli* DH5α strain harboring plasmid pMG4/pKDT was kindly provided by Prof. Thomas K. Wood (Pennsylvania State University, USA). *A. hydrophila* WAF38 is an AHL producing our laboratory strain. *C. violaceum* 12472, *C. violaceum* CVO26, *A. hydrophila* WAF38 and *P. aeruginosa* PAO1 were maintained on Luria--Bertani (LB) broth at 28 and 37°C, respectively.

Plant Material and Preparation of Extracts
------------------------------------------

*Mangifera indica* leaves were collected locally from the campus of Aligarh Muslim University, Aligarh, India. The mature dried leaves were finely ground and extract was prepared as described previously ([@B60], [@B59]). The extracts and fractions were dried by rotatory evaporator at 40°C followed by successive extraction of collected dried plant material with other solvents (benzene, ethyl acetate, acetone, methanol and ethanol). Each fraction was dried and store at 4°C. The yield of each fraction was determined. DMSO (0.1%) was used to reconstitute dry extracts for experimental purpose.

Assay for Quorum Sensing Inhibition
-----------------------------------

Inhibition of QS by plant extracts was analyzed as described ([@B32]). Briefly, test organism *C. violaceum* (ATCC 12472; 10^6^ CFU/ml) was overlaid in 5 ml soft agar on the agar plates. Wells of 8 mm were made and loaded with 100 μl of solvent or plant extracts (100--1000 μg/ml). Fractions showing strong activity were repeated at lower concentrations using paper disk and tested by disk diffusion method. Inhibition of pigment production by the indicator strain around disk was considered as positive for QS interference. Similarly, assay was adopted with *C. violaceum* CVO26 with the addition of standardized 10 μM of C6-HSL (Sigma--Aldrich, St. Louis, MO, USA).

MIC Determination
-----------------

Broth dilution method was used to determine the minimum inhibitory concentration (MIC) of plant extracts. Tetrazolium salt (*p*-iodonitrotetrazolium violet) was used as an indicator of growth as described earlier ([@B3]).

Violacein Inhibition Assay
--------------------------

Production of violacein pigment by *C. violaceum* in the presence and absence of plant extract was analyzed by violacein extraction and quantified spectrophotometrically ([@B9]). Briefly, 16--18 h (OD~600\ nm~ = 0.1) grown culture was incubated in Erlenmeyer flasks containing Luria broth supplemented with C6-HSL (10 μM) in the absence and presence of plant extracts and incubated at 28°C for 24 h. For quantification, bacterial cells were collected and the pellet was dissolved in 1 ml DMSO. Cell debris was removed by centrifugation (13000 *g*; 10 min) and absorbance of soluble violacein was read at 585 nm using microplate reader (Thermo Scientific, Multiskan Ex, India). Percent inhibition of violacein production in the presence of plant extracts was measured as, \[(OD of control - OD of treated)/OD of control\] × 100. Simultaneously, cell viability of CVO26 strain was determined. Bacterial viable count was made by agar plate count method.

Analysis of Bacterial Growth Curve
----------------------------------

Effect of sub-MICs of ML extract on growth curve of PAO1 and WAF38 was determined. Bacterial culture was inoculated into LB broth (100 ml) with and without the extract. The flask was incubated at 37°C for 24 h. OD of the culture was monitored at 600 nm at interval of 2 h to plot the growth curve.

Effect on Quorum Sensing Regulated Virulence Factors
----------------------------------------------------

### Assay for *LasB* Elastolytic Activity

The method described by [@B2] was adopted to determine elastolytic activity. Bacterial culture was treated with plant extracts for 16 h at 37°C. Both treated and untreated culture supernatant (100 μL each) was mixed with 900 μl of elastin congo red (ECR) buffer (100 mM Tris, 1 mM CaCl~2~, pH 7.5) containing 20 mg of elastin congo red (ECR, Sigma, USA). This mixture was incubated at 37°C on shaker incubator for 3 h followed by removal of insoluble ECR by centrifugation. The absorption of the congo red was determined by reading the supernatant at 495 nm and LB medium with or without ML extract was included as negative control.

### Assay for Proteolytic Activity with Azocasein

The method described by [@B28] was adopted to determine proteolytic activity of cell-free supernatants of test bacteria (PAO1 and WAF38) cultured with and without ML extract at sub-MICs. Briefly, culture supernatants (150 μL each) were added to 1 ml of 0.3% azocasein (Sigma, USA) in 0.05 M Tris--HCl and 0.5 mM CaCl~2~ (pH 7.5) followed by incubation at 37°C for 15 min. The reaction was stopped by adding the trichloroacetic acid (l0%, 0.5 ml). After centrifugation the absorbance was read at 400 nm.

### Assay for Pyocyanin Production

Method of [@B16] was used to check the pyocyanin production. Briefly, culture supernatant (5 ml) of *P. aeruginosa* (PAO1) treated with or without ML extracts was first extracted with chloroform (3 ml) followed by re-extraction with 0.2 M HCl (1 ml). The solution was assayed for absorbance at 520 nm.

Assay for Chitinase Activity
----------------------------

Chitinase activity was measured as described previously ([@B23]) adopting a modified chitin azure assay. The filter-sterilized culture supernatant was mixed in 2:1 with 0.1 M sodium citrate buffer (pH 4.8), containing chitin azure (0.5 mg/ml) followed by incubation on a shaker for 1 week at 37°C. The absorbance was recorded at 570 nm.

Swarming Motility Assay
-----------------------

Swarming motility was determined as described earlier ([@B21]). Briefly, the medium (1% tryptone, 0.5% NaCl and 0.3% agar) with or without various Sub MIC concentration of ML extracts were point inoculated with the test cultures (*P. aeruginosa* PAO1 and *C. violaceum*). After overnight incubation diameter of swarm was measured.

Exopolysaccharide (EPS) Extraction and Estimation
-------------------------------------------------

Bacterial strains PAO1 and WAF38 were cultivated in the presence of ML extract and subsequently centrifuged to obtain supernatant and filter sterilized. Chilled absolute ethanol was added in the supernatant and left overnight to precipitate EPS at 4°C ([@B24]). The method of [@B15] was used to estimate sugar concentration.

Assay for Biofilm Inhibition
----------------------------

The effect of ML at sub-MICs was determined using biofilm formation assay ([@B36]). PAO1, WAF38 and CV 12472 cultures were grown overnight in the presence and absence of ML extract in microtitre plate. The biofilm was visualized after staining with crystal violet solution (0.1%). After removing planktonic cells by rinsing the microtitre plate, the dye was solubilized in the ethanol and quantified spectrophotometrically at 470 nm.

*In Situ* Visualization of Biofilms
-----------------------------------

Scanning electron microscopy (SEM) was done to visualize the biofilm *in situ*. The method described for biofilm formation on glass cover slip was adopted as described earlier ([@B23]). Briefly, biofilms were grown for 24 h on glass coverslips using 12 well plate with plant extract treated and untreated cultures of PAO1. Non-adhered cells from the cover slips were removed by rinsing with with distilled water and processed for SEM using standard protocol.

Effect on β-Galactosidase Activity
----------------------------------

Method of [@B19] was used to determine the β-galactosidase reporter activity. Supernatants of PAO1 treated with mango extracts were extracted with ethyl acetate for QS signal molecules (AHLs). Then, 0.5 ml of ethyl acetate extract was incubated with 2 ml of reporter *E. coli* MG4 (pKDT17) strain at 30°C for 5 h in shaker-incubator. Pellet was collected (3200 × *g* for 15 min) and suspended in an equal volume of Z buffer (Na~2~HPO~4~, 0.06 M; NaH~2~PO~4~, 0.04 M; KCl, 0.01 M; MgSO~4~, 0.001 M; β-mercaptoethanol, 0.05 M; pH 7.0). To 1 ml of cell suspension, 1 ml of Z buffer, 200 μl chloroform and 100 μl of 0.1% SDS was added to lyse the cells, and 0.4 ml of *[O]{.smallcaps}*-nitrophenol-β-[D]{.smallcaps}-galactopyranoside (4 mg/ml in PBS) was added ([@B8]). Reaction was stopped after the development of yellow color by adding 1 ml of 1 M Na~2~CO~3~. Absorbance was measured at 420 and 550 nm. Units of β-galactosidase were calculated as 1000 × OD~420\ nm~ - (1.75 × OD~550\ nm~) / time × volume× OD~600\ nm~.

Effect on *Caenorhabditis elegans* Survival
-------------------------------------------

The method of [@B33] was adopted to study *in vivo* efficiency of ML extract in *Caenorhabditis elegans* (*C. elegans*) nematode infection model. Briefly, the young adult nematodes were infected with PAO1 in the 24-well microtitre plate and incubated at 25°C for 12 h. After incubation, *C. elegans* from the wells were washed thrice with M9 buffer (KH~2~PO~4,~ 3 g; Na~2~HPO~4,~ 6 g; NaCl, 5 g; 1 M MgSO~4,~ 1 ml; and distilled water 1000 ml) to remove surface-bound bacteria. Around 10 infected worms were transferred to the wells of microtitre plate containing 10% LB broth in M9 buffer and incubated at 25°C with or without plant extract.

Determination of Total Phenolic of Plant Extract
------------------------------------------------

The total phenolic content of the ML extract was assayed by the method of [@B49], as described earlier ([@B61]).

Gas Chromatography--Mass Spectrometry (GC-MS) Analysis of Plant Extracts
------------------------------------------------------------------------

The compositions of the ML extract was analyzed by gas chromatography as described earlier by [@B59].

Ultra Performance Liquid Chromatography (UPLC) Analysis
-------------------------------------------------------

The method describe earlier by [@B7] was adapted with little modification. Briefly, methanolic extracts of MLwas analyzed for the phenolics on a Shimadzu ultra performance liquid chromatography (UPLC) system comprised of two LC-20AD-XR pumps, SIL-20A-XR autosampler, and SPD-M20A photodiode array detector (PDA) controlled by Class VP software (ver 7.4, SP3) attached to a Shim-pack XR-ODS-II column (3.0 mm × 150 mm; 2.2 μ). A linear gradient of 3.5% phosphoric acid (solvent A) and acetonitrile (solvent B) with flow rate of 0.7 ml/min was used. In the gradient, solvent B was initially 15% for 2 min and increased to 20% by 3 min. The solvent B concentration was further increased to 60% from 3 to 10 min and held for 1 min and returned to 15% by 14 min. The chromatogram was collected from 200 to 600 nm and general phenolics were analyzed at 280 nm.

Statistical Analysis
--------------------

All experiments were performed in triplicate and the data obtained from the experiments were presented as mean values with or without standard deviation and the differences between control and test were analyzed using Student's *t*-test.

Results
=======

Different extracts of ML were obtained in petroleum ether, benzene, ethyl acetate, acetone and methanol and tested for QS modulatory activity against *C. violaceum* (CV12472). The methanol fraction showed dose-dependent anti-QS activity being best effective without any growth inhibition at 400 μg/ml concentration (**Table [1](#T1){ref-type="table"}**). At higher concentrations pigment inhibition, a determinant of anti-QS activity was accompanied by growth inhibition of CV12472. The ethyl acetate fraction also exhibited anti-QS activity but only at 1800 μg/ml concentration. Acetone fraction inhibited pigments at 400 and 800 μg/ml; however, it also inhibited bacterial growth at the same concentration. Petrol and benzene fractions showed no inhibition of QS at tested concentrations (200--1600 μg/ml). To assess the effect of ML fractions on QS-regulated functions MIC was determined. The MIC of the extract against CVO26 was 1000 μg/ml, and against *P. aeruginosa* PAO1 and *A. hydrophila* WAF38, the MIC was 2000 μg/ml.

###### 

Inhibition of *C. violaceum* (CV12472) pigments by different fractions of *Mangifera indica*.

  Fractions       Concentration (μg/ml)   Zone of inhibition (mm)        
  --------------- ----------------------- ------------------------- ---- ----
  Ethyl acetate   225                     --                        --   --
                                                                         
                                                                         
                  450                     --                        --   --
                                                                         
                                                                         
                  900                     --                        --   --
                                                                         
                                                                         
                  1800                    5                         --   5
                                                                         
                                                                         
  Acetone         100                     --                        --   --
                                                                         
                                                                         
                  200                     --                        --   --
                                                                         
                                                                         
                  400                     18                        15   3
                                                                         
                                                                         
                  800                     21                        16   5
                                                                         
                                                                         
  Methanol        200                     --                        --   --
                                                                         
                                                                         
                  400                     15                        --   15
                                                                         
                                                                         
                  800                     21                        2    19
                                                                         
                                                                         
                  1600                    25                        8    17
                                                                         
                                                                         
                                                                         

Data are the mean value of three replicate. Values are round off to nearest whole number. Petroleum ether and benzene fractions do not show any activity; --, No activity. Total inhibition = total zone of pigment inhibition including growth inhibition, if any.

Effects of ML Extract on QS-Regulated Virulence Factors/Traits
--------------------------------------------------------------

The methanol fraction demonstrated dose-dependent interference in QS activity as shown by reduced violacein production in CVO26 supplemented with synthetic AHL. It almost completely reduced the violacein production upto 83.6% at the concentration of 800 μg/ml. The effect was significant even at 400, 200, and 100 μg/ml concentrations with 55.6, 32.1, and 8.2% reductions, respectively (**Figures [1A,B](#F1){ref-type="fig"}**).

![**(A)** Inhibition of violacein by methanol extract of *Mangifera indica* (leaf) in *C. violaceum* at the concentration of 200 (1), 400 (2), 800 (3), and 1600 (4) μg/ml. **(B)** Quantitative assessment of violacein inhibition in CVO26 at sub-inhibitory concentrations of *M. indica* (leaf) extract. All of the data are presented as mean ± standard deviation. ^∗^*p* ≤ 0.05, ^∗∗∗^*p* ≤ 0.001.](fmicb-08-00727-g001){#F1}

**Table [2](#T2){ref-type="table"}** shows the dose-dependent effect of plant extracts on virulence factors in PAO1. Elastase activity decreased substantially at sub-inhibitory concentrations (100--800 μg/ml) of mango leaf (ML) extract with 17.6--76.2% reduction compared to the control. Similarly, a significant concentration-dependent decrease (43.8--56%) of total protease production was observed in the culture supernatant of *P. aeruginosa* at 200--800 μg/ml extract. Pre-treatment with extract (100, 200, 400, and 800 μg/ml) caused significant reduction of pyocyanin pigment (69.7, 80.2, 85.6, and 88.8%, respectively) in a dose-dependent manner (**Table [2](#T2){ref-type="table"}**). Chitinase activity also decreased with ML extract but this decrease was significant (55.3%) only at 800 μg/ml conc. Similarly, a concentration-dependent decrease in the production of EPS was recorded in the treated culture of PAO1 compared to control. The extract exhibited statistically significant reduction of 50.2 and 58.3% in EPS at 400 and 800 μg/ml, respectively. In the present study, ML extract significantly reduced flagella-mediated swarming motility of *P. aeruginosa* PAO1 (25.2--73.7%) at tested sub-MICs (**Table [2](#T2){ref-type="table"}** and **Figure [3](#F3){ref-type="fig"}**).

###### 

Effect of *Mangifera indica* on inhibition of quorum sensing (QS) regulated virulence factors in *P. aeruginosa* PAO1.

  Concentration (μg/ml)    Elastase activity^a^      Total protease^b^        Pyocyanin production^c^   Chitinase activity^d^    EPS production^e^        Swarming motility^f^   Biofilm formation^g^
  ------------------------ ------------------------- ------------------------ ------------------------- ------------------------ ------------------------ ---------------------- -------------------------
  Control                  0.181 ± 0.04              1.091 ± 0.04             4.4 ± 0.34                0.141 ± 0.019            1.110 ± 0.02             67 ± 2.5               0.406 ± 0.04
  100                      0.149 ± 0.03 (17.6)       0.857 ± 0.03 (21.4)      1.33 ± 0.33 (69.7)^∗∗^    0.110 ± 0.02 (21.9)      0.678 ± 0.02 (38.9)      50 ± 2.0 (25.2)        0.256 ± 0.03 (36.9)
  200                      0.110 ± 0.02 (39.2)^∗^    0.613 ± 0.03 (43.8)^∗^   0.87 ± 0.20 (80.2)^∗∗^    0.09 ± 0.01 (36.1)       0.601 ± 0.02 (45.8)      34 ± 2.0 (48.9)^∗^     0.210 ± 0.02 (48.2)^∗^
  400                      0.090 ± 0.02 (50.2)^∗^    0.547 ± 0.02 (49.8)^∗^   0.63 ± 0.03 (85.6)^∗∗∗^   0.081 ± 0.01 (42.5)      0.552 ± 0.01 (50.2)^∗^   26 ± 1.5 (60.3)^∗^     0.179 ± 0.03 (55.9)^∗^
  800                      0.043 ± 0.02 (76.2)^∗∗^   0.479 ± 0.02 (56.0)^∗^   0.49 ± 0.02 (88.8)^∗∗∗^   0.063 ± 0.01 (55.3)^∗^   0.462 ± 0.02 (58.3)^∗^   17 ± 1.5 (73.7)^∗∗^    0.112 ± 0.02 (72.4)^∗∗^
  Azithromycin (2 μg/ml)   0.048 ± 0.01              0.389 ± 0.02             0.2 ± 0.009               0.04 ± 0.01              0.34 ± 0.02              21.6 ± 2.3             0.095 ± 0.01
                                                                                                                                                                                 

a

Elastase activity is expressed as the absorbance at 495 nm.

b

Total protease activity is expressed as the absorbance at 600 nm

.

c

Pyocyanin concentrations were expressed as micrograms of pyocyanin produced per μg of total protein.

d

Chitinase activity is expressed as the absorbance at 570 nm.

e

EPS production is expressed as absorbance at 480 nm.

f

Swarming motility is expressed as diameter of swarm in mm.

g

Biofilm formation is expressed at 470 nm after incubation with crystal violet. Data represent mean and standard deviation of three independent experiments. Values in parentheses indicate percent reduction over control.

∗

p

≤ 0.05,

∗∗

p

≤ 0.005,

∗∗∗

p

≤ 0.001.

Effect of the methanol extract on virulence factors of *A. hydrophila* WAF38 is represented in **Table [3](#T3){ref-type="table"}**. The extract demonstrated significant reduction in total protease activity (54--69%). EPS production in WAF38 strain was also reduced in a dose-dependent manner and significant decrease of 41.9, 52.2, and 59% was observed at 250, 500, and 1000 μg/ml concentration of the extract. Growth curve analysis showed that sub-MICs of *M. indica* did not cause significant change in the growth of *P. aeruginosa* PAO1 and *A. hydrophila* (Supplementary Figure [S1](#SM1){ref-type="supplementary-material"})

###### 

Effect of *Mangifera indica* leaf extract on inhibition of QS regulated virulence factors in *Aeromonas hydrophila* WAF-38.

  Concentration (μg/ml)   Total protease^a^          EPS production^b^         Biofilm formation^c^
  ----------------------- -------------------------- ------------------------- ---------------------------
  Control                 0.589 ± 0.051              0.748 ± 0.021             0.226 ± 0.006
  125                     0.271 ± 0.015 (53.9)^∗^    0.661 ± 0.027 (11.6)      0.099 ± 0.004 (56.1)^∗^
  250                     0.223 ± 0.006 (62.1)^∗^    0.434 ± 0.009 (41.9)^∗^   0.087 ± 0.009 (61.5)^∗^
  500                     0.200 ± 0.010 (66.0)^∗∗^   0.357 ± 0.005 (52.2)^∗^   0.054 ± 0.006 (76.1)^∗∗^
  1000                    0.182 ± 0.004 (69.1)^∗∗^   0.306 ± 0.018 (59.0)^∗^   0.040 ± 0.003 (82.3)^∗∗∗^
                                                                               

a

Total protease activity is expressed as the absorbance at 600 nm

.

b

EPS production is expressed as absorbance at 480 nm

.

c

Biofilm formation is expressed at 470 nm after incubation with crystal violet. Data represent mean and standard deviation of three independent experiments. Values in parentheses indicate percent reduction over control.

∗

p

≤ 0.05,

∗∗

p

≤ 0.005,

∗∗∗

p

≤ 0.001.

### Effect on Biofilm Formation

Sub-MICs were tested for biofilm inhibition in *P. aeruginosa* (PAO1) using crystal violet assay. Biofilm formation was significantly inhibited by 48, 56, and 72% at 200, 400, and 800 μg/ml concentrations, respectively (**Table [2](#T2){ref-type="table"}**). SEM images also revealed reduction in the biofilm formation when treated with extracts (**Figure [2](#F2){ref-type="fig"}**). The impact of ML extract on WAF38 biofilm formation was also studied and a maximum reduction of 82.3% at 1000 μg/ml was recorded. At lower concentrations, there was also significant reduction in the range of 56--76% (**Table [3](#T3){ref-type="table"}**).

![**Scanning electron microscopic (SEM) images for inhibition of biofilm of *Pseudomonas aeruginosa* PA01 at Sub minimum inhibitory concentrations.** Images shown the effect on biofilm formation at 400 μg/ml **(B)** and 800 μg/ml **(C)** concentration of *Mangifera indica* (methanol) extract compared to control **(A)**.](fmicb-08-00727-g002){#F2}

![**Inhibition of swarming motility in *P. aeruginosa* PAO1 by sub-MICs of methanol extract of *M. indica* (leaf),** **(A)** Untreated control; **(B)** 200 μg/ml; **(C)** 400 μg/ml; **(D)** 800 μg/ml.](fmicb-08-00727-g003){#F3}

### Effect on β-Galactosidase Activity

The las-controlled transmission was determined by inhibition of β-galactosidase activity. Mango extract at 800 μg/ml showed reduction in β-galactosidase in *E. coli* MG4/pKDT17 by 64% (**Figure [4](#F4){ref-type="fig"}**), suggesting direct inhibition of *las*-controlled transcription by ML bioactives. The effect was also significant at 200 and 400 μg/ml concentration.

![**Effect of *M. indica* (methanol) extract on β-galactosidase activity in *E. coli* MG4/pKDT17.** All of the data are presented as mean ± SD. ^∗∗^*p* ≤ 0.01, ^∗∗∗^*p* ≤ 0.001.](fmicb-08-00727-g004){#F4}

### Anti-infective Potential of Plant Extracts in *C. elegans* Nematode Model

In this model, *C. elegans* was infected with *P. aeruginosa* followed by treatment with ML extract. In the absence of extracts, 100% mortality of *C. elegans* was recorded after 72 h demonstrating the PAO1 pathogenicity. On the other hand, *C. elegans* pre-infected with PAO1 and maintained in the presence of ML extract (800 μg/ml) displayed an enhanced survival rate of 72% (**Figure [5](#F5){ref-type="fig"}**). The ML extracts could not exhibit significant mortality of *C. elegans* at the tested concentration.

![**Anti-infection potential of *M. indica* (methanol) extract on *P. aeruginosa* infected *C. elegans*.** Figure represents effect of mango extract (800 μg/ml) on the survival of *C. elegans*. Nematodes were pre-infected with *P. aeruginosa* and treated in the presence and absence of mango extract for 4 days. Graph represents the average of three independent experiments and SD.](fmicb-08-00727-g005){#F5}

Phytochemical Analysis of Leaf Extract
--------------------------------------

The total phenolic content (mg GAE/g) of extract was assayed by the Folin--Ciocalteu method and 497.6 gallic acid equivalents (mg/g) was recorded. Gas chromatography--mass spectrometry (GC-MS) analysis revealed 16 components in methanol fraction using a direct similarity search. The major compounds identified were pyrogallol (15.6%), benzoic acid, 4-hydroxy (12.09%), n-hexadecanoic acid (9.96%), 4H-pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl (8.48%) as evident from the GC-MS spectra (**Table [4](#T4){ref-type="table"}** and Supplementary Figures [S2](#SM1){ref-type="supplementary-material"}, [S3](#SM1){ref-type="supplementary-material"}). It is possible to extend the number of phytoconstiuents using chemometric techniques. We further analyzed the active methanolic fraction of ML with UPLC (**Figure [6](#F6){ref-type="fig"}**). The UPLC analysis revealed the presence of 7--8 major phytocompounds at different wavelength and distinct time of retention. The retention time of compounds was found between 6 and 13 min. The spectral analysis of major peaks revealed highest absorbance at around 270 nm suggesting their identity as phenolics. However, these peaks remained to be identified.

###### 

Phytochemicals of *Mangifera indica* extract as identified by GC-MS analysis.

  Peak no.   Components                                                          Retention time   Area (%)
  ---------- ------------------------------------------------------------------- ---------------- ----------
  1\.        1,3,5-Triazine-2,4,6-triamine                                       3.66             6.66
  2\.        1,2,3-Propanetriol, monoacetate                                     3.88             1.40
  3\.        4H-Pyran-4-one, 2,3-dihydro-3,5-dihydroxy-6-methyl                  4.60             8.48
  4\.        2-Furancarboxaldehyde, 5-(hydroxymethyl)                            5.90             4.72
  5\.        1,2,3-Benzenetriol                                                  8.42             15.60
  6\.        Benzoic acid, 4-hydroxy                                             10.36            12.09
  7\.        1,2,3,4,5,6,7,8-Octahydro-2-naphthol, 4-methylene-2,5,5-trimethyl   11.61            1.03
  8\.        Tetradecanoic acid                                                  12.63            1.72
  9\.        Pluchidiol                                                          13.17            1.19
  10\.       Hexadecanoic acid, methyl ester                                     14.28            2.58
  11\.       n-Hexadecanoic acid                                                 14.70            9.96
  12\.       9,12,15-Octadecatrienoic acid, methyl ester                         15.99            1.71
  13\.       Phytol                                                              16.11            2.24
  14\.       9,12,15-Octadecatrienoic acid, (Z,Z,Z)-                             16.40            6.22
  15\.       Stigmast-5-en-3-ol, (3.beta.)-                                      29.47            2.32
  16\.       Lupeol                                                              30.26            1.07
                                                                                                  

![**HPLC profile of *Mangifera indica* (methanol) leaf extract.** Twenty microliter of extracts (1 mg/ml) were injected and analyzed using photo diode array detector on a C18 (250 mm × 4.6 mm ID × 5 μm) reverse phase column in a gradient of 3.5% aqueous phosphoric acid and acetonitrile. Chromatograms in **(A)** represent various polyphenolics detected at 280 nm. Chromatograms in the **(B)** represent analysis of different peaks as indicated in **(A)** in the range of 200--600 nm. mAu, milli absorbance units. For clarity of data, *y*-axis scales are different.](fmicb-08-00727-g006){#F6}

Discussion
==========

In many bacteria virulence factors are regulated through QS, a cell density-dependent global gene regulatory mechanism. Interference of QS circuits is considered as potential strategy to attenuate bacterial pathogenecity. In an ongoing program we have identified some potential plants with anti-QS activity in preliminary screening including *M. indica* L. ([@B61]). In this study ML extract is subjected to sequential fractionation in different organic solvents and tested for QS interference by reduction in violacein production in *C. violaceum* 12472. Violacein production by *C. violaceum* is regulated by CviIR-dependent QS system ([@B32]). Therefore, any modulation of pigment in *C. violaceum* is considered direct evidence of QS interference.

The methanol fraction of ML apparently reduced the AHL-dependent pigment production, indicating interference of QS-controlled function. Further, interference of QS by the methanol fraction is also evident as it inhibited the violacein production in CVO26 without interfering the growth of *C. violaceum*. A similar effect on the violacein inhibition has been reported by *C. cyminum* and clove oil ([@B37]; [@B23]). *C. violaceum* was used as the model for screening QS inhibitors because of the easy detection of the purple-colored pigmentation (violacein) in the indicator organism. Therefore, based on the violacein inhibition and lack of growth inhibition of the indicator organism CVO26, the methanol fraction was found the most active and thus further tested against *P. aeruginosa* PAO1 and *A. hydrophila* WAF38 to assess broad spectrum anti-QS activity because these organisms involve a different QS system than CVO26.

*Pseudomonas aeruginosa* secretes a range of QS-regulated virulence factors including elastase, protease and chitinase ([@B2]). The bacterial hydrolytic enzymes such as elastase and protease are known to affect the host cell proteins in the infected tissues and facilitate bacterial invasion and growth. In the present investigation, preincubation with the extract produced concentration-dependent inhibition of elastase and protease production. These data corroborated with the literature where, elastase activity, total proteolytic and chitinase activity of *P. aeruginosa* was decreased to varying levels (10--90%) by plant extracts and essential oils ([@B53]; [@B22]). Pyocyanin is another important virulence factor produced under QS-regulation. The role of pyocyanin is well documented in pathogenesis especially in cystic fibrosis ([@B58]). A significant dose-dependent decrease (*p* ≤ 0.001) was observed with ML extract in all strains, being maximum in PAO1 (88.8%). Similar reduction in pyocyanin production was recorded in extracts of *Terminalia chebula* ([@B44]).

Quorum sensing mediated by AHLs are known to play significant role in biofilm formation. We found that the ML extract at Sub-MICs inhibited the biofilm biomass significantly (*P* ≤ 0.005) with no significant growth inhibition on PAO1. [@B43] showed that surface adhesion followed by microcolony formation is promoted by surface conditioning.

Scanning electron microscopy images revealed ML extract efficiently reduced biofilm formed by bacteria which have further demonstrated that ML extract treatment reduces the biofilm strength. The possible interference in biofilm formation might be due to reducing surface adhesion or subsequent step of biofilm formation. The extract inhibiting QS is expected to adversely affect biofilm forming capacity ([@B13]). The results obtained in our study are in agreement with activity of extracts of *C. viminalis*, *Quercus virginiana*, *Tetrazygia bicolor* ([@B2]), *Lagerstroemia speciosa* ([@B47]), and *Sclerocarya birrea* ([@B45]).

Factors closely associated with biofilm formation of *P. aeruginosa* like swarming motility and EPS production were also evaluated in this study. Production of EPS is a prerequisite for the biofilm maturation ([@B56]), a QS regulated trait ([@B54]). Therefore, reduction in EPS production is due to QS interference by plant extracts ([@B1]). It is hoped that plant extract significantly (*p* ≤ 0.05) reducing EPS will possibly reduce the resistance level of the pathogen in sessile mode. Treatment of PAO1 by plant extract reduces the EPS production. A dose-dependent decrease was observed in swarming motility of PAO1. It has been shown that flagellar-driven motility is required for surface attachment initiation in biofilm development ([@B40]). Therefore, inhibition in flagellar synthesis by the extracts would facilitate the reduced swarming migration. Thus, these extracts might have indirectly impacted biofilm formation by pathogens at least in part by disturbing AHL-mediated QS-system.

Virulence factors like exo-proteases production, EPS production and the biofilm formation are regulated by *ahyRI* QS system ([@B57]). ML extract demonstrated dose-dependent significant (*p* ≤ 0.005) reduction in the total protease and EPS production by *A. hydrophila* WAF38. Biofilm formation was also inhibited in a concentration-dependent manner by sub-MICs of extracts tested. The data obtained in our study for protease and biofilm inhibition indicated that the extract is potentially acting on the AhyRI system rendering the production of C4-HSL impaired. Similar findings against *Aeromonas* sp. were reported with chestnut honey and its extracts at 0.2 g/ml concentration, inhibiting biofilm up to 61% over control ([@B50]).

The addition of ML extract decreased β-galactosidase luminescence in *E. coli* MG4/pKDT17 significantly (*p* ≤ 0.005) at sub-MICs. The results of the assay demonstrate reduction in AHL production under the effect of plant extract inhibits*las*-controlled transcription. It has been demonstrated that AHL is needed in combination with the *LasR* to achieve the maximal activation of the *lasB* gene, ([@B38]). Therefore, a critical global regulatory system is formed by *LasR* and AHL for the expression of *P. aeruginosa* virulence factors. The dependence of *lasB-lacZ* expression on AHL concentration has been reported ([@B39]). Therefore, it is evident that reduction in the β-galactosidase activity in this study relates to reduce AHL levels through interference of *lasB* gene expression. Our results corroborates with the observations on *L. speciosa* fruit extract ([@B47]) and eugenol ([@B63]).

Further, observation on the protection of *C. elegans* infected with *P. aeruginosa* PAO1 in the presence of ML extract provided a proof of the anti-virulence property. Our findings are in support of earlier works, which demonstrated similar activity of garlic extracts ([@B41]).

*Mangifera indica* L is rich in polyphenolic content and GC-MS analysis further confirmed the presence of an array of compounds. Pyrogallol was detected as the major compound which is known to exhibit antagonism against the QS signaling molecule AI-2 and virulence factors of *Vibrio* sp. ([@B11]; [@B35]).

Inhibition of multiple traits regulated by QS by ML extract indicated its broad-spectrum activity through the QS interference possibly at multiple targets. Various compounds present in the extract might also influence QS by indirectly acting on the other primary target linked to QS functioning. The compounds like trifluoromethyl ketones, phenothiazine and phenothiazine thioridazine that inhibit proton motive force linked activities such as motility of Gram negative bacteria, and also inhibitor of the proton motive force-dependent efflux pump system of bacteria and QS system ([@B52]). The possible role of various synthetic and natural compounds has been reported as efflux pump inhibitor of Gram negative bacteria and QS interference ([@B5]). Therefore, presence of such compounds in the plant extracts may also influence the anti-QS activity through the efflux pump inhibition and needs further investigation. On the other hand, pyrogallol detected in this study is known to inhibit QS through generation of H~2~O~2~ that somehow interfere with the expression of bioluminescence in *Vibrio* ([@B14]).

Our data indicated that ML extracts and its active constituents as a potential candidate for exploiting as anti-infective agent in modern phytomedicine. Further identifying and exploring active compounds as novel anti-QS agent that effectively inhibit virulence and demonstrate the therapeutic utility against drug resistant bacteria are needed.
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